Literature DB >> 2503190

Autoimmune haemolytic anaemia associated with interferon alfa-2a in a patient with mycosis fungoides.

L R Braathen, P Stavem.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2503190      PMCID： PMC1836763          DOI： 10.1136/bmj.298.6689.1713-b

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

1.  Alpha-interferon and immune hemolytic anemia.

Authors:  L P Akard; R Hoffman; L Elias; J H Saiers
Journal:  Ann Intern Med       Date:  1986-08       Impact factor: 25.391

2.  Autoimmune thyroid disease in interferon-treated patients.

Authors: 
Journal:  Lancet       Date:  1985-07-13       Impact factor: 79.321

3.  Primary hypothyroidism associated with interferon therapy of breast cancer.

Authors:  I S Fentiman; B S Thomas; F R Balkwill; R D Rubens; J L Hayward
Journal:  Lancet       Date:  1985-05-18       Impact factor: 79.321

4.  Interferon-induced parotitis and epididymitis.

Authors:  P C Bevan
Journal:  Lancet       Date:  1985-09-07       Impact factor: 79.321

5.  Autoimmune haemolytic anaemia occurring in a patient with mycosis fungoides.

Authors:  S I White; J R Marsden; J M Marks; S Proctor
Journal:  Br J Dermatol       Date:  1984-04       Impact factor: 9.302

6.  Immune thrombocytopenia following alpha-interferon therapy in patients with cancer.

Authors:  P McLaughlin; M Talpaz; J R Quesada; A Saleem; B Barlogie; J U Gutterman
Journal:  JAMA       Date:  1985-09-13       Impact factor: 56.272

Review 7.  The interferons.

Authors:  J L Toy
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

8.  Intralesional interferon in the treatment of early mycosis fungoides.

Authors:  J M Wolff; J A Zitelli; B S Rabin; K A Smiles; E Abell
Journal:  J Am Acad Dermatol       Date:  1985-10       Impact factor: 11.527

9.  Treatment of cutaneous lymphoma with etretinate.

Authors:  A L Claudy; B Rouchouse; S Boucheron; J C Le Petit
Journal:  Br J Dermatol       Date:  1983-07       Impact factor: 9.302

10.  Recombinant leukocyte A interferon: an active agent in advanced cutaneous T-cell lymphomas.

Authors:  P A Bunn; K A Foon; D C Ihde; D L Longo; J Eddy; C F Winkler; S R Veach; J Zeffren; S Sherwin; R Oldham
Journal:  Ann Intern Med       Date:  1984-10       Impact factor: 25.391
  10 in total
  3 in total

Review 1.  [Interferon therapy and autoimmunity].

Authors:  J Fritzsch; J Krug; H J Heberling
Journal:  Med Klin (Munich)       Date:  1997-05-15

Review 2.  Toxicities of Immunotherapy for the Practitioner.

Authors:  Jeffrey S Weber; James C Yang; Michael B Atkins; Mary L Disis
Journal:  J Clin Oncol       Date:  2015-04-27       Impact factor: 44.544

Review 3.  Clinical toxicity of the interferons.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1994-02       Impact factor: 5.606
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.